The detrimental effect of serum albumin on the re-spreading of a dipalmitoyl phosphatidylcholine Langmuir monolayer is counteracted by a fluorocarbon gas

Biochimica et Biophysica Acta - Biomembranes

Volumn 1768, Issue 3, 2007, Pages 490-494

  Gerber, Frédéric ^a,b   Krafft, Marie Pierre ^a   Vandamme, Thierry F ^b  

^a INSTITUT CHARLES SADRON   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Acute respiratory distress syndrome; Dipalmitoyl phosphatidylcholine; Fluorescence microscopy; Fluorocarbon; Langmuir monolayer; Lung surfactant; Perfluorooctyl bromide; Serum albumin

Indexed keywords

DIPALMITOYLPHOSPHATIDYLCHOLINE; FLUOROCARBON; LUNG SURFACTANT; PERFLUOROOCTYL BROMIDE; PLASMA PROTEIN; SERUM ALBUMIN;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; CONCENTRATION RESPONSE; FLUORESCENCE MICROSCOPY; IMAGE ANALYSIS; ISOTHERM; LANGMUIR BLODGETT FILM; LIPID MONOLAYER; LIQUID VENTILATION; OXYGEN TRANSPORT; PRIORITY JOURNAL;

1,2-DIPALMITOYLPHOSPHATIDYLCHOLINE; ANIMALS; CATTLE; FLUOROCARBONS; GASES; MICROSCOPY, FLUORESCENCE; PHASE TRANSITION; SERUM ALBUMIN, BOVINE; WATER;

BOVINAE;

EID: 33847035574     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2006.09.022     Document Type: Article

References (26)

1. Zasadzinski J.A., Ding J., Warriner H.E., Bringezu F., and Waring A.J. The physics and physiology of lung surfactants. Curr. Opin. Colloid Interface Sci. 6 (2001) 506-513
2. Schürch S. Surface tension at low lung volume: dependence on time and alveolar size. Respir. Physiol. 48 (1982) 339-355
3. Goerke J., and Gonzales J. Temperature dependence of dipalmitoyl phosphatidylcholine monolayer stability. J. Appl. Physiol. 51 (1981) 1108-1114
4. Warriner H.E., Ding J., Waring A.J., and Zasadzinski J.A. A concentration-dependent mechanism by which serum albumin inactivates replacement lung surfactants. Biophys. J. 82 (2002) 835-842
5. Lacaze-Masmonteil T. Exogenous surfactant therapy: newer developments. Semin. Neonatol. 8 (2003) 433-440
6. Pison U., Seeger W., Buchhorn R., Joka T., Brand M., Obertacke U., et al. Surfactant abnormalities in patients with respiratory failure following multiple trauma. Am. Rev. Respir. Dis. 140 (1989) 1033-1039
7. Seeger W., Walmrath D., Menger M., and Neuhof H. Increased lung vascular permeability after arachidonic acid and hydrostatic challenge. J. Appl. Physiol. 61 (1986) 1781-1789
8. Balis J.U., Shelley S.A., McCue M.J., and Rappaport M.S. Mechanisms of damage to the lung surfactant system. Exp. Mol. Pathol. 14 (1971) 243-262
9. Fuchimukai T., Fuchiwara T., Takahashi A., and Enhorning G. Artificial pulmonary surfactant inhibited by proteins. J. Appl. Physiol. 62 (1987) 429-437
10. Seeger W., Grube C., Günther A., and Schmidt R. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations. Eur. Respir. J. 6 (1993) 971-977
11. Holm B.A., Notter R.H., and Finkelstein J.N. Surface property changes from interaction of albumin with natural lung surfactant and extracted lung lipids. Chem. Phys. Lipids 38 (1985) 287-298
12. Gerber F., Krafft M.P., Vandamme T.F., Goldmann M., and Fontaine P. Preventing crystallization of phospholipids in monolayers: a new approach to lung surfactant therapy. Angew. Chem., Int. Ed. 44 (2005) 2749-2752
13. Gerber F., Krafft M.P., Vandamme T.F., Goldmann M., and Fontaine P. Fluidization of a dipalmitoylphosphatidylcholine monolayer by fluorocarbon gases. Potential use in lung surfactant therapy. Biophys. J. 90 (2005) 3184-3192
14. Riess J.G. Fluorous micro- and nanophases with a biomedical perspective. Tetrahedron 58 (2002) 4113-4131
15. Riess J.G. Oxygen carriers ("Blood substitutes")-Raison d'être, chemistry, and some physiology. Chem. Rev. 101 (2001) 2797-2920
16. Krafft M.P. Fluorocarbons and fluorinated amphiphiles in drug delivery and biomedical research. Adv. Drug Delivery Rev. 47 (2001) 209-228
17. Krafft M.P. Basic principles and recent advances on fluorinated self-assemblies and colloidal systems. In: Gladysz J.A., Horváth I., and Curran D.P. (Eds). Handbook of Fluorous Chemistry (2004), Wiley-VCH, Weinheim 478-490
18. Krafft M., Vandamme T.F., Gerber F., Shibata O., US Patent 60/563,690, April 19, 2004; PCT/IB 2005/001020 April 18, 2005.
19. Riess J.G. Fluorous materials for biomedical uses. In: Gladysz J.A., Horváth I., and Curran D.P. (Eds). Handbook of Fluorous Chemistry (2004), Wiley-VCH, Weinheim 521-573
20. Leach C.L., Greenspan J.S., Rubenstein D., Shaffer T.H., Wolfson M.R., Jackson J.C., et al. Partial liquid ventilation with perflubron in premature infants with severe respiratory distress syndrome. N. Engl. J. Med. 335 11 (1996) 761-766
21. Knobler C.M., and Desai R.C. Phase transitions in monolayers. Annu. Rev. Phys. Chem. 43 (1992) 207-236
22. Lösche M., Sackmann E., and Möhwald H. A fluorescence microscopic study concerning the phasediagram of phospholipids. Ber. Bunsenges. Phys. Chem. 87 (1983) 848-852
23. Cho D., Narsimhan G., and Franses E.I. Interactions of spread lecithin monolayers with bovine serum albumin in aqueous solution. Langmuir 13 (1997) 4710-4715
24. Wang X., Zhang H., Cui G., and Li J. Structure, characterization and stability of mixed lipid/protein monolayer at the air/water interface. J. Mol. Liq. 90 (2001) 149-156
25. Wang X., Zhang Y., Wu J., Wang M., Cui G., Li J., et al. Dynamical and morphological studies on the adsorption and penetration of human serum albumin into phospholipid monolayers at the air/water interface. Colloid Surf., B Biointerfaces 23 (2002) 339-347
26. Wang X., He Q., Zheng S., Brezesinski G., Möhwald H., and Li J. Structural changes of phospholipid monolayers caused by coupling of human serum albumin: A GIXD study at the air/water interface. J. Phys. Chem., B 108 (2004) 14171-14177